Ajinomoto's $546M Acquisition of US-based Forge Biologics
jason tuinstra 4OfaTz6SdYs unsplash

Japan’s Ajinomoto agreed to acquire U.S.-based genetic medicines maker Forge Biologics Holdings for 82.8 billion yen ($546 million).

The transaction is expected to be completed in December 2023 pending regulatory approvals, Ajinomoto said a release.

Ajinomoto, whose primary business is in seasonings and processed foods, has a healthcare segment that focuses on drugs derived from amino acids.

Forge, based in the U.S. state of Ohio, is a contract development and manufacturing organization (CDMO) for gene-based therapies. Ajinomoto said Forge will integrate with its own AminoScience platform to work on new treatment options for rare diseases.

($1 = 151.7400 yen)

Source: Reuters

Related Articles

General, Investors/Business
News
Imagine if you could put an ultra-thin, transparent solar sheet on your window to generate energy, not just from sunlight but also artificial lights from inside your room? Seen as the most promising next-generation solar cell, this technology, called perovskite, is exactly what Japanese start-up Enecoat Technologies is trying to develop. Start-ups such as this are called "deep tech". They are small firms who are merging high-tech engineering innovation with scientific discovery. The hope is that it will lead to the development of transformational products.
General, Investors/Business
News
Japan's promised economic stimulus must be big enough to exceed the economy's output gap of about 15 trillion yen ($100 billion), a senior ruling party official said on Sunday. The remarks add to growing calls among ruling party officials for hefty spending to ease the strain from rising inflation on households. On monetary policy, Shindo said while the Bank of Japan must eventually exit ultra-easy policy, doing so now would be premature as Japan's economy and wage growth remain weak.
General
News
Foreign nationals with “specified skilled worker” visa status are once again entering Japan following the easing of border control measures in March related to the coronavirus. Foreign workers have sometimes waited years for permission to enter the country. Many have found employment at nursing homes, which have suffered labor shortages.
Investors/Business
News
Asia-Pacific industrial and logistics properties present a massive opportunity still in early innings. The majority of global institutional investors still have little to no exposure to this fast-growing, dynamic sector. Here are four examples of the trades shaping the Asian industrial real estate markets and why we are high conviction on these investment themes.